{"id":13032,"date":"2007-11-02T12:51:17","date_gmt":"2007-11-02T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=13032"},"modified":"2018-03-11T11:22:44","modified_gmt":"2018-03-11T17:22:44","slug":"13032","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/13032\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 2 de novembro de 2007"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN-11-02-07.pdf\">vers\u00e3o para impress\u00e3o<\/a><\/p>\n<p>*******************************************************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas sobre sa\u00fade animal de 2 de novembro de 2007<\/strong><br \/>\nCopyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon, DVM, MBA <br \/>\n*******************************************************************<br \/>\nNAS NOTICIAS:<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de ganhos<\/u><br \/>\nalfarma<br \/>\nColinas<br \/>\nImmuCellName<br \/>\nVetoquinol <br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<\/u><br \/>\nID do animal<br \/>\nIDEXX<br \/>\nintervir<br \/>\nMerial<br \/>\nVseguro <br \/>\n&nbsp;<br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nEM BREVE!<br \/>\n2007 MERCADOS DE CONTROLE DE PULGAS E HEARTWORM DOS EUA<br \/>\n&nbsp;<br \/>\nENCOMENDE AGORA COM DESCONTO ANTECIPADO<br \/>\n&nbsp;<br \/>\n2007 foi um ano de mudan\u00e7as din\u00e2micas nos mercados de pulgas, carrapatos e dirofilariose, com uma s\u00e9rie de lan\u00e7amentos de novos produtos de players novos e estabelecidos no segmento.<br \/>\n&nbsp;<br \/>\nA Brakke Consulting publicar\u00e1 em breve nosso \u00faltimo relat\u00f3rio anual sobre os mercados de controle de pulgas e dirofilariose dos EUA. Al\u00e9m da nossa pesquisa anual com veterin\u00e1rios de pequenos animais, o relat\u00f3rio deste ano incluir\u00e1 a cobertura de muitos novos produtos lan\u00e7ados este ano, incluindo Advantage Multi, ProMeris, Vectra 3D e Comfortis. <br \/>\n&nbsp;<br \/>\nO relat\u00f3rio sobre os mercados de controle de pulgas e dirofilariose dos EUA estar\u00e1 dispon\u00edvel por um pre\u00e7o de compra de $4.995 se solicitado at\u00e9 QUARTA-FEIRA, 21 DE NOVEMBRO e $5.500 ap\u00f3s essa data.&nbsp; <br \/>\n&nbsp;<br \/>\nEntre em contato com o Dr. Lynn Fondon em (972) 243-4033 ou <a href=\"mailto:lfondon@brakkeconsulting.com\">lfondon@brakkeconsulting.com<\/a> para encomendar o relat\u00f3rio ou para obter mais informa\u00e7\u00f5es, ou visite nosso site e baixe o formul\u00e1rio de pedido em <a href=\"https:\/\/brakkeconsulting.com\/pt\/studies\/flea.html\/\">https:\/\/brakkeconsulting.com\/studies\/flea.html<\/a> <br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a>. <br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nRELEASES DE RESULTADOS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Alpharma reportou resultados financeiros para o terceiro trimestre de 2007. As receitas de sa\u00fade animal aumentaram 3% para $91 milh\u00f5es, em compara\u00e7\u00e3o com $88 milh\u00f5es em 2006. Excluindo os efeitos cambiais, as receitas aumentaram 2% em rela\u00e7\u00e3o aos n\u00edveis de 2006, impulsionadas pelo crescimento nos mercados internacionais. (comunicado de imprensa da empresa) <br \/>\n&nbsp;<br \/>\n&gt; A Vetoquinol reportou resultados para o terceiro trimestre de 2007. A receita total do terceiro trimestre chegou a 55 milh\u00f5es de euros ($78 milh\u00f5es), um aumento de 8,2% em compara\u00e7\u00e3o com o terceiro trimestre do ano anterior. O crescimento foi relatado em todos os n\u00edveis, tanto em termos de esp\u00e9cies como de regi\u00f5es geogr\u00e1ficas, com um desempenho particularmente forte na Am\u00e9rica do Norte, onde a aquisi\u00e7\u00e3o da Vet Solutions no final de 2006 impulsionou significativamente as vendas. (site da companhia) <br \/>\n&nbsp;<br \/>\n&gt; A Colgate-Palmolive Company anunciou os resultados do terceiro trimestre de 2007. As vendas da Hill&#039;s Pet Nutrition cresceram 12% para $464 milh\u00f5es, enquanto o volume unit\u00e1rio cresceu 5% durante o trimestre. (comunicado de imprensa da empresa) <br \/>\n&nbsp;<br \/>\n&gt; A ImmuCell Corporation anunciou os resultados de suas opera\u00e7\u00f5es para os tr\u00eas meses encerrados em 30 de setembro de 2007. As vendas de produtos diminu\u00edram em 7% para $983.000 em compara\u00e7\u00e3o com o mesmo per\u00edodo em 2006. A Empresa reportou lucro l\u00edquido de $354.000 durante os tr\u00eas meses. per\u00edodo encerrado em 30 de setembro de 2007 em compara\u00e7\u00e3o com $171.000 durante o mesmo per\u00edodo em 2006. Como resultado da rescis\u00e3o do contrato de licenciamento da Pfizer Animal Health com rela\u00e7\u00e3o ao Mast Out, a Empresa reconheceu a receita diferida restante de pagamentos n\u00e3o reembols\u00e1veis recebidos da Pfizer. e amortizou o custo n\u00e3o amortizado restante dos direitos de tecnologia adquiridos em novembro de 2004. Isto resultou em um aumento l\u00edquido no lucro antes do imposto de renda de aproximadamente $602.000 durante o terceiro trimestre de 2007, sem impacto no caixa. (comunicado de imprensa da empresa)&nbsp; <br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Merial anunciou o lan\u00e7amento do Manual Merck\/Merial para Sa\u00fade de Animais de Estima\u00e7\u00e3o, o primeiro guia completo de sa\u00fade para donos de animais de estima\u00e7\u00e3o. O manual \u00e9 baseado no Manual Veterin\u00e1rio Merck, utilizado por veterin\u00e1rios h\u00e1 mais de 50 anos. (comunicado de imprensa da empresa)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A Intervet anunciou o licenciamento total do USDA para o Circumvent PCV, um vetor de baculov\u00edrus morto tipo 2, vacina contra circov\u00edrus su\u00edno. A vacina demonstrou reduzir a mortalidade e proporcionar um desempenho de crescimento melhorado e consistente em compara\u00e7\u00e3o com su\u00ednos n\u00e3o vacinados. O Circumvent PCV pode ser utilizado em su\u00ednos a partir das tr\u00eas semanas de idade. (Alerta de carne de porco)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A IDEXX anunciou o lan\u00e7amento do Avian Health Profile para o VetTest Chemistry Analyzer, um painel para detec\u00e7\u00e3o de doen\u00e7as em aves de estima\u00e7\u00e3o. O painel cont\u00e9m seis das an\u00e1lises qu\u00edmicas do sangue mais comumente usadas para detectar doen\u00e7as; testes adicionais podem ser adicionados ao painel. O painel pode ser usado em diversas esp\u00e9cies, incluindo papagaios, periquitos, cacatuas, calopsitas, araras, conures e can\u00e1rios. (Farm\u00e1cia Animal)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Vsurance, Inc., fornecedora de seguro sa\u00fade para animais de estima\u00e7\u00e3o, informou que concordou em adquirir a Animal-ID, uma empresa que fornece aos produtores de gado, propriet\u00e1rios de confinamentos e outros ferramentas f\u00e1ceis de usar para controle de estoque, rastreamento e gerenciamento . Os termos financeiros n\u00e3o foram divulgados. (not\u00edcias ad hoc)&nbsp; <br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n&nbsp;<br \/>\n&gt; SU\u00cd\u00c7A \u2013 L\u00cdNGUA AZUL As autoridades veterin\u00e1rias su\u00ed\u00e7as registaram o primeiro caso de doen\u00e7a da l\u00edngua azul no pa\u00eds, depois de vacas terem sido infectadas perto de Basileia. O Servi\u00e7o Veterin\u00e1rio Federal anunciou no domingo que seis dos 19 animais de um rebanho testaram positivo para febre catarral ovina. Uma zona de prote\u00e7\u00e3o com raio de 20 quil\u00f4metros foi instalada ao redor da fazenda. (Swissinfo.org)<br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 FONTE DE RECALL DE CARNE Uma investiga\u00e7\u00e3o conjunta entre a Ag\u00eancia Canadense de Inspe\u00e7\u00e3o de Alimentos e o Servi\u00e7o de Inspe\u00e7\u00e3o e Seguran\u00e7a Alimentar do USDA identificou uma fonte prov\u00e1vel do surto generalizado de infec\u00e7\u00f5es por E. coli O157:H7 ligadas \u00e0 agora extinta Topps Meat Company. A CFIA forneceu ao FSIS padr\u00f5es PFGE, ou impress\u00f5es digitais de DNA, de testes de cortes de carne bovina de uma empresa canadense, Ranchers Beef, Ltd., que forneceu cortes para a Topps. Embora a Ranchers Beef tenha encerrado suas opera\u00e7\u00f5es em 15 de agosto, alguns produtos permaneceram armazenados e foram coletados e testados pela CFIA. Esse padr\u00e3o de PFGE correspondia aos de pacientes doentes e aos testes positivos realizados pelo Departamento de Sa\u00fade de Nova York em produtos que mais tarde foram recolhidos pela Topps. (Local de carnes) <br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 RELAT\u00d3RIO DO C\u00c2NCER O Instituto Americano para Pesquisa do C\u00e2ncer e o Fundo Mundial de Pesquisa do C\u00e2ncer divulgaram um relat\u00f3rio que analisou mais de 7.000 estudos cient\u00edficos sobre os riscos do c\u00e2ncer. O relat\u00f3rio concluiu que o excesso de gordura corporal aumenta o risco de v\u00e1rios cancros e ofereceu uma s\u00e9rie de recomenda\u00e7\u00f5es para a preven\u00e7\u00e3o do cancro, incluindo a limita\u00e7\u00e3o da ingest\u00e3o de carne vermelha e carne processada a n\u00e3o mais de 18 on\u00e7as por semana. A National Cattlemen&#039;s Beef Association rapidamente registou a sua oposi\u00e7\u00e3o ao relat\u00f3rio, citando uma recente \u201cAvalia\u00e7\u00e3o da Carne Vermelha e do Cancro\u201d realizada por cientistas independentes, que avaliou todos os estudos epidemiol\u00f3gicos dispon\u00edveis sobre a carne vermelha e seis tipos de cancro e concluiu que n\u00e3o havia liga\u00e7\u00e3o causal. (Alimentos)<br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<br \/>\n&nbsp;<br \/>\nNossa empresa vem divulgando a \u00e1rea de diagn\u00f3stico h\u00e1 algum tempo. \u00c9 bom ter uma empresa como a IDEXX que continua a provar que existem muitas aplica\u00e7\u00f5es e que h\u00e1 lucros neste campo. Talvez mais importante ainda, o campo \u00e9 vital para a nossa seguran\u00e7a, como mostra a hist\u00f3ria do USDA\/E. coli. \u00c9 lament\u00e1vel que a investiga\u00e7\u00e3o n\u00e3o tenha evitado o surto. \u00c9 um princ\u00edpio da minha cren\u00e7a empresarial que os maus operadores ser\u00e3o descobertos; a \u00fanica quest\u00e3o \u00e9 quantas pessoas eles machucaram nesse \u00ednterim.<br \/>\n&nbsp;<br \/>\nJohn Mannhaupt<br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<br \/>\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n2735 Villa Creek, Su\u00edte 140<br \/>\nDallas, TX 75234 EUA<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>vers\u00e3o para impress\u00e3o ******************************************************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 2 de novembro de 2007 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************************************************ NAS NOT\u00cdCIAS: not\u00edcias sobre lucros Alpharma Hill&#039;s ImmuCell Vetoquinol outras not\u00edcias Animal-ID IDEXX Intervet Merial Vsurance ************************************************************************ EM BREVE! MERCADOS DE CONTROLE DE PULGAS E DIROFILARIO DOS EUA DE 2007 ENCOMENDE AGORA PARA DESCONTO ANTECIPADO 2007 foi um ano de mudan\u00e7as din\u00e2micas nos mercados de pulgas, carrapatos e dirofilariose, com uma s\u00e9rie de novos lan\u00e7amentos de produtos de participantes novos e estabelecidos no segmento. A Brakke Consulting publicar\u00e1 em breve nosso \u00faltimo relat\u00f3rio anual sobre os mercados de controle de pulgas e dirofilariose dos EUA. Al\u00e9m da nossa pesquisa anual com veterin\u00e1rios de pequenos animais, o relat\u00f3rio deste ano incluir\u00e1 a cobertura dos muitos novos produtos lan\u00e7ados este ano, incluindo Advantage Multi, ProMeris, Vectra 3D e Comfortis. O relat\u00f3rio sobre os mercados de controle de pulgas e dirofilariose dos EUA estar\u00e1 dispon\u00edvel por um pre\u00e7o de compra de $4.995 se encomendado at\u00e9 QUARTA-FEIRA, 21 DE NOVEMBRO, e $5.500 ap\u00f3s essa data. Entre em contato com o Dr. Lynn Fondon pelo telefone (972) 243-4033 ou pelo e-mail lfondon@brakkeconsulting.com para pr\u00e9-encomendar o relat\u00f3rio ou para obter mais informa\u00e7\u00f5es, ou visite nosso site e baixe o formul\u00e1rio de pedido em https:\/\/brakkeconsulting.com\/studies\/flea.html www.BrakkeConsulting.com. ******************************************************************** DIVULGA\u00c7\u00d5ES DE LUCROS DA EMPRESA &gt; Resultados financeiros reportados pela Alpharma<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/13032\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-13032","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/13032\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ******************************************************************* Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 2, 2007 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS: &nbsp; earnings news Alpharma Hill&rsquo;s ImmuCell Vetoquinol &nbsp; other news Animal-ID IDEXX Intervet Merial Vsurance &nbsp; &nbsp; ******************************************************************* COMING SOON! 2007 US FLEA CONTROL AND HEARTWORM MARKETS &nbsp; ORDER NOW FOR EARLY-BIRD DISCOUNT &nbsp; 2007 has been a year of dynamic change in the flea, tick and heartworm markets, with a number of new product introductions from both new and established players in the segment. &nbsp; Brakke Consulting will soon be publishing our latest annual report on the US Flea Control and Heartworm Markets.&nbsp; In addition to our annual survey of small animal veterinarians, this year&rsquo;s report will include coverage of the many new products introduced this year, including Advantage Multi, ProMeris, Vectra 3D, and Comfortis. &nbsp; The report on the US Flea Control &amp; Heartworm Markets will be available for a purchase price of $4,995 if ordered by WEDNESDAY, NOVEMBER 21, and $5,500 after that date.&nbsp; &nbsp; Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com to pre-order the report or for more information, or visit our website and download the order form at https:\/\/brakkeconsulting.com\/studies\/flea.html &nbsp; www.BrakkeConsulting.com. &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt; Alpharma reported financial resultsView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/13032\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2007-11-02T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-11T17:22:44+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for November 2, 2007\",\"datePublished\":\"2007-11-02T18:51:17+00:00\",\"dateModified\":\"2018-03-11T17:22:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/\"},\"wordCount\":1182,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2007-11-02T18:51:17+00:00\",\"dateModified\":\"2018-03-11T17:22:44+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/13032\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/13032\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for November 2, 2007\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/13032\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ******************************************************************* Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 2, 2007 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS: &nbsp; earnings news Alpharma Hill&rsquo;s ImmuCell Vetoquinol &nbsp; other news Animal-ID IDEXX Intervet Merial Vsurance &nbsp; &nbsp; ******************************************************************* COMING SOON! 2007 US FLEA CONTROL AND HEARTWORM MARKETS &nbsp; ORDER NOW FOR EARLY-BIRD DISCOUNT &nbsp; 2007 has been a year of dynamic change in the flea, tick and heartworm markets, with a number of new product introductions from both new and established players in the segment. &nbsp; Brakke Consulting will soon be publishing our latest annual report on the US Flea Control and Heartworm Markets.&nbsp; In addition to our annual survey of small animal veterinarians, this year&rsquo;s report will include coverage of the many new products introduced this year, including Advantage Multi, ProMeris, Vectra 3D, and Comfortis. &nbsp; The report on the US Flea Control &amp; Heartworm Markets will be available for a purchase price of $4,995 if ordered by WEDNESDAY, NOVEMBER 21, and $5,500 after that date.&nbsp; &nbsp; Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com to pre-order the report or for more information, or visit our website and download the order form at https:\/\/brakkeconsulting.com\/studies\/flea.html &nbsp; www.BrakkeConsulting.com. &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt; Alpharma reported financial resultsView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/13032\/","og_site_name":"Brakke Consulting Website","article_published_time":"2007-11-02T18:51:17+00:00","article_modified_time":"2018-03-11T17:22:44+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/13032\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/13032\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for November 2, 2007","datePublished":"2007-11-02T18:51:17+00:00","dateModified":"2018-03-11T17:22:44+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/13032\/"},"wordCount":1182,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/13032\/","url":"https:\/\/brakkeconsulting.com\/zh\/13032\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2007-11-02T18:51:17+00:00","dateModified":"2018-03-11T17:22:44+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/13032\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/13032\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/13032\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for November 2, 2007"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/13032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=13032"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/13032\/revisions"}],"predecessor-version":[{"id":13067,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/13032\/revisions\/13067"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=13032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=13032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=13032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}